Cardlytics (CDLX) PT Lowered to $1 at Evercore ISI, removed from TAP Underperform List Mar 6, 2026 08:42AM
Cardlytics (CDLX) PT Lowered to $0.90 at BofA Securities: "2026 is likely to be a transition year" Mar 5, 2026 08:30AM
Cardlytics (CDLX) Tops Q4 EPS by 28c, Beats on Revenue Mar 4, 2026 04:04PM
Cardlytics names David Evans as chief financial officer Dec 18, 2025 08:06AM
Cardlytics (CDLX) Tops Q3 EPS by 26c, Misses on Revenue Nov 5, 2025 04:21PM


Oct 2, 2025 08:05AM Cardlytics cuts 30% of workforce in cost reduction initiative
Oct 2, 2025 08:00AM Cardlytics to cut 24% of workforce in restructuring plan
Sep 22, 2025 06:13AM Increasing unusual option volume: CDLX INFY ORLA SRRK KBWB LDI BHF
Sep 18, 2025 10:23AM Cardlytics (CDLX) Mentioned as Positive at Citron Research
Aug 6, 2025 04:21PM Cardlytics (CDLX) Tops Q2 EPS by 26c, provides guidance
Jul 15, 2025 09:30AM Cardlytics launches new customer insights dashboards for advertisers
May 20, 2025 09:33AM Cardlytics (CDLX) launches Cardlytics Rewards Platform
May 7, 2025 04:20PM Cardlytics (CDLX) Tops Q1 EPS by 23c, Beats on Revenue; Offers Q2 Revenue Guidance
Mar 16, 2025 09:31AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Mar 13, 2025 10:02AM Cardlytics (CDLX) PT Lowered to $3 at Evercore ISI
Mar 13, 2025 08:50AM Cardlytics (CDLX) PT Lowered to $3 at Craig-Hallum
Mar 13, 2025 06:50AM Cardlytics (CDLX) PT Lowered to $2.50 at BofA Securities
Mar 13, 2025 06:19AM Needham Reiterates Hold Rating on Cardlytics (CDLX)
Mar 12, 2025 04:09PM Cardlytics (CDLX) Tops Q4 EPS by 47c ; Offers Guidance
Mar 10, 2025 12:33PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Mar 9, 2025 09:08AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 28, 2025 01:33PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 24, 2025 05:49PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 22, 2025 09:48AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 20, 2025 03:43PM Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman
Feb 18, 2025 06:52PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 17, 2025 12:24PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 15, 2025 07:34AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Feb 13, 2025 01:18PM Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman
Feb 11, 2025 02:33PM Faruqi & Faruqi Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
Feb 9, 2025 09:13AM Faruqi & Faruqi Reminds Cardlytics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - CDLX
Feb 6, 2025 04:00PM CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Feb 6, 2025 02:45PM Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman
Jan 31, 2025 08:27AM Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman
Jan 29, 2025 04:00PM CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cardlytics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 28, 2025 05:42PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Jan 26, 2025 08:53AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics
Jan 23, 2025 01:42PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Jan 21, 2025 05:23PM ROSEN, A LEADING LAW FIRM, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Jan 19, 2025 08:53PM ROSEN, A LEADING LAW FIRM, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Jan 18, 2025 03:48PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Jan 17, 2025 01:53PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX
Nov 7, 2024 06:16PM Cardlytics (CDLX) Tops Q3 EPS by 42c
Oct 11, 2024 07:24AM Evercore ISI Starts Cardlytics (CDLX) at In Line
Aug 8, 2024 07:12AM Needham Downgrades Cardlytics (CDLX) to Hold
Aug 7, 2024 05:18PM Cardlytics (CDLX) Tops Q2 EPS by 31c
Aug 7, 2024 04:10PM Cardlytics (CDLX) Appoints Amit Gupta as CEO
Jun 20, 2024 08:12AM BofA Securities Assumes Cardlytics (CDLX) at Neutral
Jun 18, 2024 07:50AM Northland Starts Cardlytics (CDLX) at Outperform